The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...

In a deal that could top $1 billion, Merck & Co has teamed up with US biotech Janux Therapeutics to bring T-cell immunotherapies to cancer patients. The agreement sees San Diego-based Janux in ...

Celonic Group, a Swiss-Based Quality CDMO, is integrating Merck’s Breez micro-bioreactor platform into its process ...

Alpha Teknova (TKNO) and Pluristyx announced that the companies are collaborating to produce and commercialize Pluristyx’s PluriFreeze product ...

A new era of cell therapy has well and truly arrived with the iPSC field setting a trailblazing fire with its potential to develop fully scalable, off-the-shelf cell lines reducing the cost of ...

But it's not only private schools that are proceeding with caution. North Carolina State University announced a hiring freeze last month, citing "the uncertain impacts of the presidential ...

But it's not only private schools that are proceeding with caution. North Carolina State University announced a hiring freeze last month, citing "the uncertain impacts of the presidential ...

A few sprinkles cannot be ruled out across extreme southeastern Oklahoma on Saturday afternoon but are not likely. Cooler weather will prevail as the trough exits the region. A cold front will ...

Through their development of iPSCs, Pluristyx recognized the critical importance of cellular biopreservation across the cell therapy workflow. In the process, the company identified a novel ...

The floor of the Frankfurt stock exchange is cleaned as the German share price index DAX graph is displayed on a large screen in Frankfurt, Germany, March 13, 2025. REUTERS/Staff/File photo ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator.